153 related articles for article (PubMed ID: 35986249)
41. Influence of hospital characteristics on operative death and survival of patients after major cancer surgery in Ontario.
Simunovic M; Rempel E; Thériault ME; Coates A; Whelan T; Holowaty E; Langer B; Levine M
Can J Surg; 2006 Aug; 49(4):251-8. PubMed ID: 16948883
[TBL] [Abstract][Full Text] [Related]
42. Influence of primary site on metastatic distribution and survival in stage IV colorectal cancer.
Suthananthan AE; Bhandari M; Platell C
ANZ J Surg; 2018 May; 88(5):445-449. PubMed ID: 28512795
[TBL] [Abstract][Full Text] [Related]
43. Effectiveness of Combining Bevacizumab With First-Line Chemotherapy Regimens for Metastatic Colorectal Cancer in Real-World Practice.
Bang YH; Hong YS; Lee JS; Lee KW; Han HS; Kim SY; Kim JW; Kim HK; Kim JW; Eun CK; Kim TW; Kim JE
Clin Colorectal Cancer; 2021 Jun; 20(2):101-112.e6. PubMed ID: 33223477
[TBL] [Abstract][Full Text] [Related]
44. Colorectal cancer liver metastases - a population-based study on incidence, management and survival.
Engstrand J; Nilsson H; Strömberg C; Jonas E; Freedman J
BMC Cancer; 2018 Jan; 18(1):78. PubMed ID: 29334918
[TBL] [Abstract][Full Text] [Related]
45. Temporal development in survival, and gender and regional differences in the Swedish population of patients with synchronous and metachronous metastatic colorectal cancer.
Osterlund E; Glimelius B
Acta Oncol; 2022 Oct; 61(10):1278-1288. PubMed ID: 36152023
[TBL] [Abstract][Full Text] [Related]
46. Clinicopathological features of HER2 positive metastatic colorectal cancer and survival analysis of anti-HER2 treatment.
Yang L; Li W; Lu Z; Lu M; Zhou J; Peng Z; Zhang X; Wang X; Shen L; Li J
BMC Cancer; 2022 Apr; 22(1):355. PubMed ID: 35365123
[TBL] [Abstract][Full Text] [Related]
47. The Impact of Primary Tumor Location in Synchronous Metastatic Colorectal Cancer: Differences in Metastatic Sites and Survival.
Brouwer NPM; van der Kruijssen DEW; Hugen N; de Hingh IHJT; Nagtegaal ID; Verhoeven RHA; Koopman M; de Wilt JHW
Ann Surg Oncol; 2020 May; 27(5):1580-1588. PubMed ID: 31792717
[TBL] [Abstract][Full Text] [Related]
48. [Analysis of related factors of prognosis after surgical treatment of patients with non-metastatic colorectal cancer and construction of a normagram prediction model].
Liu SX; Zhang L; Shi YK; Han XH
Zhonghua Zhong Liu Za Zhi; 2022 Feb; 44(2):167-172. PubMed ID: 35184461
[No Abstract] [Full Text] [Related]
49. Is Survival for Patients with Resectable Lung Metastatic Colorectal Cancer Comparable to Those with Resectable Liver Disease? Results from the South Australian Metastatic Colorectal Registry.
Patel D; Townsend AR; Karapetis C; Beeke C; Padbury R; Roy A; Maddern G; Roder D; Price TJ
Ann Surg Oncol; 2016 Oct; 23(11):3616-3622. PubMed ID: 27251133
[TBL] [Abstract][Full Text] [Related]
50. Mismatch repair status and synchronous metastases in colorectal cancer: A nationwide cohort study.
Nordholm-Carstensen A; Krarup PM; Morton D; Harling H;
Int J Cancer; 2015 Nov; 137(9):2139-48. PubMed ID: 25921209
[TBL] [Abstract][Full Text] [Related]
51. The Prognostic Value of Locoregional Interventions for BRAF V600E Metastatic Colorectal Cancer: A Retrospective Cohort Analysis.
Ye LF; Ji XM; Ren C; Wang ZQ; Lin CP; Chen DL; Cai YQ; Jin Y; Qiu MZ; Du ZM; Xi SY; Zhang DS; Wang F; Wang FH; Xu RH; Li YH; Wang DS
Biomolecules; 2021 Aug; 11(9):. PubMed ID: 34572480
[TBL] [Abstract][Full Text] [Related]
52. Gender disparities in metastatic colorectal cancer survival.
Hendifar A; Yang D; Lenz F; Lurje G; Pohl A; Lenz C; Ning Y; Zhang W; Lenz HJ
Clin Cancer Res; 2009 Oct; 15(20):6391-7. PubMed ID: 19789331
[TBL] [Abstract][Full Text] [Related]
53. Primary tumor location and bevacizumab effectiveness in patients with metastatic colorectal cancer.
Boisen MK; Johansen JS; Dehlendorff C; Larsen JS; Østerlind K; Hansen J; Nielsen SE; Pfeiffer P; Tarpgaard LS; Holländer NH; Keldsen N; Hansen TF; Jensen BB; Jensen BV
Ann Oncol; 2013 Oct; 24(10):2554-2559. PubMed ID: 23864097
[TBL] [Abstract][Full Text] [Related]
54. Effect of Hospital Cancer Designation on use of Multimodal Therapy and Survival of Metastatic Colorectal Cancer: A State-Wide Analysis.
Meier J; Murimwa G; Nehrubabu M; DiMartino L; Singal AG; Karagkounis G; Yopp A; Zeh HJ; Polanco PM
Ann Surg Oncol; 2024 Apr; 31(4):2591-2597. PubMed ID: 38245645
[TBL] [Abstract][Full Text] [Related]
55. Clinical and molecular characterisation of hereditary and sporadic metastatic colorectal cancers harbouring microsatellite instability/DNA mismatch repair deficiency.
Cohen R; Buhard O; Cervera P; Hain E; Dumont S; Bardier A; Bachet JB; Gornet JM; Lopez-Trabada D; Dumont S; Kaci R; Bertheau P; Renaud F; Bibeau F; Parc Y; Vernerey D; Duval A; Svrcek M; André T
Eur J Cancer; 2017 Nov; 86():266-274. PubMed ID: 29055842
[TBL] [Abstract][Full Text] [Related]
56. Characteristics and survival of interval and sporadic colorectal cancer patients: a nationwide population-based cohort study.
Erichsen R; Baron JA; Stoffel EM; Laurberg S; Sandler RS; Sørensen HT
Am J Gastroenterol; 2013 Aug; 108(8):1332-40. PubMed ID: 23774154
[TBL] [Abstract][Full Text] [Related]
57. The impact of primary tumor location in patients with metastatic colorectal cancer: a Korean Cancer Study Group CO12-04 study.
Byun JH; Ahn JB; Kim SY; Kang JH; Zang DY; Kang SY; Kang MJ; Shim BY; Baek SK; Kim BS; Lee KH; Lee SI; Cho SH; Sohn BS; Kim S; Hwang IG; Nam EM; Seo BG; Oh SC; Lee MA; Lee SC; Hong JH; Park YS
Korean J Intern Med; 2019 Jan; 34(1):165-177. PubMed ID: 29172407
[TBL] [Abstract][Full Text] [Related]
58. Impact of Primary Tumor Resection on Mortality in Patients with Stage IV Colorectal Cancer with Unresectable Metastases: A Multicenter Retrospective Cohort Study.
Kawamura H; Ogawa Y; Yamazaki H; Honda M; Kono K; Konno S; Fukuhara S; Yamamoto Y
World J Surg; 2021 Oct; 45(10):3230-3239. PubMed ID: 34223985
[TBL] [Abstract][Full Text] [Related]
59. Prognostic Significance of Serum Lactic Acid, Lactate Dehydrogenase, and Albumin Levels in Patients with Metastatic Colorectal Cancer.
Wei Y; Xu H; Dai J; Peng J; Wang W; Xia L; Zhou F
Biomed Res Int; 2018; 2018():1804086. PubMed ID: 30627541
[TBL] [Abstract][Full Text] [Related]
60. Pattern of relapse after curative surgery for metastatic colorectal cancer.
You JJ; Chen HC; Chen HJ; Hsieh CS; Chang MC; Yu JH; Chen YL; Chang CS
Saudi Med J; 2011 Sep; 32(9):907-12. PubMed ID: 21894352
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
